enGene Holdings Inc.
$1.56+1.96%(+$0.03)
TickerSpark Score
47/100
87
Valuation
20
Profitability
15
Growth
84
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ENGN research report →
52-Week Range1% of range
Low $1.40
Current $1.56
High $12.25
Companywww.engene.com
enGene Holdings Inc. , through its subsidiary enGene, Inc. , operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs.
- CEO
- Ronald H. W. Cooper
- IPO
- 2022
- Employees
- 56
- HQ
- Saint-Laurent, CA
Price Chart
-62.62% · this period
Valuation
- Market Cap
- $79.86M
- P/E
- -0.86
- P/S
- 0.00
- P/B
- 0.37
- EV/EBITDA
- -0.65
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -55.83%
- ROIC
- -40.54%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-117,302,000 · -112.73%
- EPS
- $-2.29 · -56.85%
- Op Income
- $-123,165,000
- FCF YoY
- -104.70%
Performance & Tape
- 52W High
- $12.25
- 52W Low
- $1.40
- 50D MA
- $6.34
- 200D MA
- $7.34
- Beta
- -0.01
- Avg Volume
- 1.47M
Get TickerSpark's AI analysis on ENGN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Start Free Trial →Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 30, 26 | CHEUNG ANTHONY TZEYEW | other | 195,000 |
| Jan 30, 26 | Giguere Lee | other | 195,000 |
| Jan 30, 26 | Nichols Alexander Julian | other | 195,000 |
| Jan 30, 26 | Daws D. Ryan | other | 220,000 |
| Jan 30, 26 | Cooper Ronald Harold Wilfred | other | 801,000 |
| Jan 30, 26 | Connolly Joan | other | 195,000 |
| Jan 30, 26 | Boyd Matthew Ross | other | 195,000 |
| Jan 30, 26 | Buck Jill | other | 195,000 |
| Sep 30, 25 | Sweiti Hussein | other | 600,000 |
| Sep 29, 25 | Sweiti Hussein | other | 0 |
Our ENGN Coverage
We haven't published any research on ENGN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ENGN Report →